Series A - Oligomerix
Investment Firm
Overview
Oligomerix develops target identification and validation technologies enhancing the drug discovery process for neurodegenerative diseases.
Announced Date
Apr 23, 2012
Funding Type
Series A
Highlights
Location
New York, United States, North America
Social
Investor Lead
N/A
Participant Investors
1
| Investor Name |
|---|
 Wheatley Partners |
Round Details and Background
Oligomerix raised $2000000 on 2012-04-23 in Series A
Oligomerix develops target identification and validation technologies enhancing the drug discovery process for neurodegenerative diseases.
Company Funding History
8
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Apr 15, 2015 |  Venture Round - Oligomerix | - | 400.0K | |
| Sep 11, 2013 | Grant - Oligomerix | 1 | - | 1.7M |
| May 22, 2013 | Series B - Oligomerix | - | 2.8M | |
| Apr 23, 2012 | Series A - Oligomerix | 3 | - | 2.0M |
Recent Activity
There is no recent news or activity for this profile.